Quanta: a David to Dialysis Industry Goliaths

Standard HD is burdensome, costly, labor-intensive, and has poor outcomes, and patients want more autonomy and flexibility. Enter Quanta: a novel HD system that combines high performance, a small footprint, and ease of use.

Read the full article » | Posted 10-12-2020

Related Articles

• Proof of Concept for Silicon Nanopore Membrane Implantable HD Posted 10-05-2026
• AWAK PD To Go Posted 10-05-2026
• The Lancet Digital Health published results of Humacyte’s Phase III clinical trial of its V007 acellular tissue engineered vessel (ATEV) HD access Posted 09-18-2026
• Humacyte, Inc. announced Robert J. Kossman, MD, FACP, FASN and Prabir Roy-Chaudhury, MD, PhD, FASN have joined the company as advisors. Posted 08-21-2026